Stay updated on KarXT for Alzheimer's Psychosis Clinical Trial
Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis Clinical Trial page.

Latest updates to the KarXT for Alzheimer's Psychosis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study record content and navigation with an access-denied message.SummaryDifference20%

- Check19 days agoChange DetectedThe header text changed capitalization from 'Find Contact Information' to 'Find contact information'. The footer revision label updated from 'Revision: v3.6.6' to 'Revision: v3.7.0', indicating a minor version update.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page's revision metadata was updated from v3.6.5 to v3.6.6.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page adds new recruitment sites and investigators (including CHU de Reims and Fondazione Policlinico A Gemelli - Rome; Jean Luc Novella at Site 2501 and Camillo Marra at Site 2303), updates informed consent language and caregiver/contraception requirements, and expands the study plan with time-to-relapse endpoints (up to Week 38) and related safety and outcome measures.SummaryDifference0.6%

- Check54 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a small behind-the-scenes update with no changes to the displayed study details.SummaryDifference0.0%

- Check69 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a newer version of the page. This update generally reflects minor corrections or updates; specific content changes are not listed.SummaryDifference0.0%

Stay in the know with updates to KarXT for Alzheimer's Psychosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis Clinical Trial page.